- Brand origin
- United States
- Main production
- United States
A leading biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics.
Is the information about Alnylam correct?
Updated: 6 April 2026 ·
Ownership data is compiled from public sources and verified where possible. Spotted an error? Suggest a correction below.
Products from Alnylam
1Alternatives to Alnylam
Brands in the same category that are not American-owned: